Current perspective on the pathogenesis of central diabetes insipidus

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 7, 2005, Pages 631-645

  Ghirardello, Stefano ^a   Malattia, Clara ^a   Scagnelli, Paola ^b   Maghnie, Mohamad ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Central diabetes insipidus; Neurophysin II gene mutation; Pathophysiology; Tumours; Vasopressin

Indexed keywords

DESMOPRESSIN; NEUROPHYSIN; VASOPRESSIN;

ABDOMINAL PAIN; ADIPSIA; AUTOIMMUNE DISEASE; AUTOSOMAL DOMINANT INHERITANCE; CENTRAL PONTINE MYELINOLYSIS; CHILDHOOD CANCER; CLINICAL FEATURE; COUGHING; CRANIOPHARYNGIOMA; DIZZINESS; EPISTAXIS; EYE IRRITATION; FLUID INTAKE; FLUSHING; GENE MUTATION; GERM CELL TUMOR; HEADACHE; HEART PALPITATION; HISTIOCYTOSIS X; HUMAN; HYPONATREMIA; IDIOPATHIC DISEASE; INFLAMMATION; INFUNDIBULUM; MOLECULAR BIOLOGY; NAUSEA; NEUROGENIC DIABETES INSIPIDUS; PATHOGENESIS; POLYDIPSIA; POLYURIA; POSTOPERATIVE COMPLICATION; REVIEW; RHINITIS; SARCOIDOSIS; SIDE EFFECT; TACHYCARDIA; THORAX PAIN; VASCULAR DISEASE; VASOPRESSIN RELEASE; VOMITING; X CHROMOSOME RECESSIVE INHERITANCE;

EID: 23644447753     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.7.631     Document Type: Review

References (93)

1. Nijenhuis M, Van Den Akker ELT, Zalm R, Franken AAM, Abbes AP, Engel H, de Wied D, Burbach JP. Familial neurohypohysial diabete insipidus in a large Dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone. J Clin Endocrinol Metab 2001; 86: 3410-3420.
2. Maghnie M, Altobelli M, di Iorgi N, Genovese E, Meloni G, Manca-Bitti ML, Cohen A, Bernasconi S. Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by vascular impairment of the inferior hypophyseal artery system. J Clin Endocrinol Metab 2004; 89: 1891-1896.
3. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, Tinelli C, Gallucci M, Bernasconi S, Boscherini B, Severi F, Arico M. Central diabetes insipidus in children and young adults. N Engl J Med 2000; 343: 998-1007.
4. Mootha SL, Barkovich AJ, Grumbach MM, Edwards MS, Gitelman SE, Kaplan SL, Conte FA. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab 1997; 82: 1362-1367.
5. Czernichow P, Pomarede R, Brauner R, Rappaport R. Neurogenic diabetes insipidus in children. Front Horm Res 1985; 13: 190-209.
6. Sklar CA, Grumbach MM, Kaplan SL, Conte AF. Hormonal and metabolic abnormalities associated with central nervous system germinoma in children and adolescents and the effect of therapy: report of 10 patients. J Clin Endocrinol Metab 1981; 52: 9-16.
7. Maghnie M, Villa A, Aricò M, Larizza D, Pezzotta S, Beluffi G, Genovese E, Severi F. Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. J Clin Endocrinol Metab 1992; 74: 795-800.
8. Maghnie M, Aricò M, Villa A; Genovese E, Beluffi G, Severi F. MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis. Am J Neuroradiol 1992; 13: 1365-1371.
9. Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Aricò M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood Langerhans cell histiocytosis. J Clin Endocrinol Metab 1998; 83: 3089-3094.
10. Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H. Lymphocytic infundibuloneuro-hypophysitis as a cause of central diabetes insipidus. N Engl J Med 1993; 329: 683-689.
11. Maghnie M, Genovese E, Sommaruga MG, Aricò M, Locatelli D, Arbustivi E, Pezzotta S, Severi F. Evolution of childhood central diabetes insipidus into panhypopituitarism with a large hypothalamic mass: Is "lymphocytic infundibulo-neurohypophysitis" in children a different entity? Eur J Endocrinol 1998; 139: 635-640.
12. Maghnie M, Genovese E, Aricò M, Villa A, Beluffi G, Campani R, Severi F. Evolving pituitary hormone deficiency is associated with pituitary vasculopathy: dynamic MR study in children with hypopituitarism, diabetes insipidus, and Langerhans cell histiocytosis. Radiology 1994; 193: 493-499.
13. Verbalis JG, Robinson AG, Moses AM. Postoperative and post-traumatic diabetes insipidus. Front Horm Res 1985; 13: 247-265.
14. Traggiai C, Stanhope R. Endocrinopathies associated with midline cerebral and cranial malformations. J Pediatr 2002; 140: 252-255.
15. Blotner H. Primary or idiopathic diabetes insipidus: a system disease. Metabolism 1958; 3: 191-200.
16. Pomarede R, Czernichow P, Rappaport R, Royer P. Le diabète pitresso-sensible de l'enfant. Arch Fr Pediatr 1980; 37: 37-44.
17. Greger NG, Kirkland RT, Clayton GW, Kirkland JL. Central diabetes insipidus: 22 years experience. Am J Dis Child 1986; 140: 551-554.
18. Bode HH. Disorders of posterior pituitary. In: Kaplan SA, ed. Clinical Pediatric Endocrinology. Philadelphia, PA: WB Saunders, 1990; 63-86.
19. Wang LC, Cohen ME, Duffner PK. Etiologies of central diabetes insipidus in children. Pediatr Neurol 1994; 11: 273-277.
20. Gu F, Jin Z, Zhang D. The etiology and clinical characteristics of central diabetes insipidus, a retrospective study of 408 cases. Zhonghua Yi Xue Za Zhi 2001; 81: 1166-1171.
21. Al-Agha AE, Thomsett MJ, Ratcliffe JF, Cotterill AM, Batch JA. Acquired central diabetes insipidus in children: a 12-year Brisbane experience. J Pediatr Child Health 2001; 37: 172-175.
22. Jaruratanasirikul S, Janjindamai S, Sriplung H, Patarakijvanich N, Vasiknanonte P. Etiologies of central diabetes insipidus in children: 15 years experience in Songklanagarind hospital, Thailand. J Med Assoc Thai 2002; 85: 765-771.
23. Maghnie M, Sommaruga MG, Beluffi G, Severi F. Role of MR imaging in the evaluation of the functional status of the posterior pituitary gland: the view of a pediatric endocrinologist. Am J Neuroradiol 1993; 14: 1443-1445.
24. Brooks BS, El Gammal T, Allison JD, Hoffmann WH. Frequency and variation of the posterior pituitary bright signal on MR images. Am J Neuroradiol 1989; 153: 1033-1038.
25. Alter CA, Bilaniuk LT. Utility of magnetic resonance imaging in the evaluation of the child with central diabetes insipidus. J Pediatr Endocrinol Metab 2002; 15 (Suppl 2): 681-687.
26. Fujisawa I, Asato R, Okumura R, Nakano Y, Shibata T, Hamanaka D, Hashimoto T, Konishi J. Magnetic resonance imaging of neurohypophyseal germinomas. Cancer 1991; 68: 1009-1014.
27. Leger J, Velasquez A, Garel C, Hassan M, Czernichow P. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 1999; 84: 1954-1960.
28. Horowitz MB, Hall WA. Central nervous system germinomas: a review. Arch Neurol 1991; 48: 652-657.
29. Kanagaki M, Miki Y, Takahashi JA, Shibamoto Y, Takahashi T, Ueba T, Hashimoto N, Konishi J. MRI and CT findings of neurohypophyseal germinoma. Eur J Radiol 2004; 49: 204-211.
30. Chen C, Okera S, Davies PE, Seva D, Crompton JL. Craniopharyngioma: a review of long-term visual outcome. Clin Exp Ophthalmol 2003; 31: 220-228.
31. Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, Moshang T, Rorke LB, Phillips PC, Sutton LN, Shu H-KG. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 2004; 58: 714-720.
32. Larijai B, Bastanhagh MH, Pajouhi M, Shadab FK, Vasigh A, Agakhani S. Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care 2003; 13: 11-15.
33. DeVile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996; 75: 108-114.
34. Lehrnbecher T, Müller-Scholden J, Danhauser-Leistner I, Sörensen N, von Stockhausen H-B. Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. Child Nerv Syst 1998; 14: 276-279.
35. Laws ER, Thapar K. The diagnosis and management of craniopharyngioma. Growth Genet Horm 1994; 10: 6-10.
36. Grois N, Prayer D, Prosch H, Minkov M, Pötschger U, Gadner H. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr Blood Cancer 2004; 43: 59-65.
37. Donadieu J, Rolon MA, Pion I, Thomas C, Doz F, Barkaoui M, Robert A, Deville A, Mazingue F, David M, Brauner R, Cabrol S, Garel C, Polak M, for the French LCH study group. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis; efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab 2004; 89: 604-609.
38. Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, Gadner H. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer 2004; 43: 594-599.
39. Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisytem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 2000; 53: 509-515.
40. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S. Clinical case seminar: Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 1995; 80: 2302-2311.
41. Ahmed SR, Aiello DP, Page R, Hopper K, Towfighi J, Santen RJ. Necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism. J Clin Endocrinol Metab 1993; 76: 1499-1504.
42. Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A. Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 2003; 149: 363-376.
43. Beressi N, Beressi P, Cohen R, Modigliani E. Lymphocytic hypophysitis. A review of 145 cases. Ann Med Intern 1999; 150: 327-341.
44. Leung GKK, Lopes MBS, Thorner MO, Vance ML, Laws ER Jr. Primary hypophysitis: a single-centre experience in 16 cases. J Neurosurg 2004; 101: 262-271.
45. De Bellis A, Colao A, Bizzarro A, Di Salle F, Coronella C, Solimeno S, Vetrano A, Pivonello R, Pisano G, Lombardi G, Bellastella A. Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus. J Clin Endocrinol Metab 2002; 87: 3825-3829.
46. De Bellis A, Colao A, Di Salle F, Muccitelli VI, Iorio S, Perrino S, Pivonello R, Coronella C, Bizzarro A, Lombardi G, Bellastella A. A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus. J Clin Endocrinol Metab 1999; 84: 3047-3051.
47. Scherbaum WA, Bottazzo GF. Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant. Lancet 1983; i: 897-901.
48. Rutishauser J, Kopp P, Gaskill MB, Kotlar TJ, Robertson GL. Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysis II gene. Eur J Endocrinol 2002; 146: 649-656.
49. Sato N, Sze G, Endo K. Hypophysitis: endocrinologic and dynamic MR findings. Am J Neuroradiol 1998; 19: 439-444.
50. Rauch F, Lenzner C, Nürnberg P, Frömmel C, Vetter U. A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus. Clin Endocrinol 1996; 44: 45-51.
51. Friberg MA, Spiess M, Rutishauser J. Degradation of wild-type vasopressin precursor and pathogenetic mutants by the proteasome. J Biol Chem 2004; 279: 19441-19447.
52. -1→Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. J Clin Endocrinol Metab 1997; 82: 51-56.
53. Braverman LE, Mancini JP, McGoldrick DM. Hereditary and idiopathic diabetes insipidus. A case report with autopsy findings. Ann Intern Med 1965; 63: 503-508.
54. Green JR, Buchan GC, Alvord EC, Swanson AG. Hereditary and idiopathic types of diabetes insipidus. Brain 1967; 90: 707-714.
55. Elias PCL, Elias LKL, Torres N, Moreira AC, Antunes-Rodrigues J, Castro M. Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clin Endocrinol 2003; 59: 511-518.
56. Christensen JH, Siggard C, Corydon TJ, de Sanctis L, Kovacs L, Robertson GL, Gregersen N, Rittig S. Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur J Hum Genet 2004; 12: 44-51.
57. Wolf MT, Dotsch J, Metzler M, Holder M, Repp R, Rascher W. A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus. Horm Res 2003; 60: 143-147.
58. Wahlstrom JT, Fowler MJ, Nicholson WE, Kovacs WJ. A novel mutation in the preprovasopressin gene identified in a kindred with autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 2004; 89: 1963-1968.
59. Baglioni S, Corona G, Maggi M, Serio M, Peri A. Identification of a novel mutation in the arginine vasopressin neurophysin II gene affecting the sixth intrachain disulfide bonds of the neurophysin II moiety. Eur J Endocrinol 2004; 151: 605-611.
60. Miyakoshi M, Kamoi K, Murase T, Sugimura Y, Oiso Y. Novel mutant vasopressin-neurophysin II gene associated with familial neurohypophyseal diabetes insipidus. Endocr J 2004; 51: 551-556.
61. Willcuts MD, Felner E, White PC. Autosomal recessive familial neurohypohyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Hum Mol Genet 1999; 8: 1303-1307.
62. Hansen LK, Rittig S, Robertson GL. Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol Metab 1997; 8: 363-372.
63. Russell TA, Ito M, Ito M, Yu RN, Martinson FA, Weiss J, Jameson JL. A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. J Clin Invest 2003; 112: 1697-1706.
64. Davies J, Murphy D. Autophagy in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus transgene. J Neuroendocrinol 2002; 14: 629-637.
65. Christensen JH, Siggaard C, Corydon TJ, Robertson GL, Gregerson N, Bolund L, Rittig S. Differential cellular handling of defective arginine-vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 2004; 89: 4521-4531.
66. Siggard C, Rittig S, Corydon TJ, Andreasen PH, Jensen TG, Andresen BS, Robrtson GL, Gregersen N, Bolund L, Pederse EB. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation. J Clin Endocrinol Metab 1999; 84: 2933-2941.
67. Ito M, Yu RN, Jameson JL. Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J Biol Chem 1999; 274: 9029-9037.
68. Christensen JH, Siggaard C, Corydon T, Robertson GL, Gregersen N, Bolund L, Rittig S. Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin Endocrinol 2004; 60: 125-136.
69. Rittig S, Siggaard. C, Ozata M, Yetkin I, Gregersen N, Pedersen EB, Robertson GL. Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine in the vasopressin moiety of the hormone precursor. J Clin Endocrinol Metab 2002; 87: 3351-3355.
70. Nagasaki H, Ito M, Yuasa H, Saito H, Fukase M, Hamada K, Ishikawa E, Katakami H, Oiso Y. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. J Clin Endocrinol Metab 1995; 80: 1352-1356.
71. Skordis N, Patsalis PC, Hettinger JA, Kontou M, Herakleous E, Krishnamani MRS, Phillips JA 3rd. A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes. Horm Res 2000; 53: 239-245.
72. Boson WL, Sarubi JC, d'Alva CB, Friedman E, Faria D, De Marco L, Wajchenberg B. A signal peptide mutation of the arginine vasopressin gene in monozygotic twins. Clin Endocrinol 2003; 58: 108-110.
73. Grant FD, Ahmadi A, Hosley CM, Majzoub JA. Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant. J Clin Endocrinol Metab 1998; 83: 3958-3964.
74. Calvo B, Bilbao JR, Urrutia I, Eizaguirre J, Gaztambide S, Castaño L. Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindred with familial neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 1998; 83: 995-997.
75. Rittig S, Robertson GL, Siggaard C, Kovács L, Gregersen N, Nyborg J, Pedersen EB. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Med Genet 1996; 58: 107-117.
76. Repaske DR, Summar ML, Krishnamani MR, Gultekin EK, Arriazu MC, Roubicek ME, Blanco M, Isaac GB, Phillips JA 3rd. Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 1996; 81: 2328-2334.
77. Heppner C, Kotzka J, Bullman C, Krone W, Müller-Wieland D. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus. J Clin Endocrinol Metab 1998; 83: 693-696.
78. Mahoney CP, Weinberger E, Bryant C, Ito M, Jameson JL, Masafumi I. Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the ΔE47 neurophysin mutation. J Clin Endocrinol Metab 2002; 87: 870-876.
79. Flück CE, Deladoëy J, Sujatha N, Zeller O, Kopp P, Mullis PE. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Δ/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NPII). Eur J Endocrinol 2001; 145: 439-444.
80. McLeod JF, Kovacs L, Gaskill MB, Rittig S, Bradley GS, Robertson GL. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation. J Clin Endocrinol Metab 1993; 77: 599A-599G.
81. Rutishauser J, Böni-Schnetzler M, Böni J, Wichmann W, Huisman T, Vallotton MB, Froesch ER. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 1996; 81: 192-198.
82. Kelley S, Robertson GL, Amico J. Antidiuretic action of oxitocin in humans. Clin Res 1992; 40: 711A (Abst).
83. Gagliardi PC, Bernasconi S, Repaske DR. Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23→Val in neurophysin II. J Clin Endocrinol Metab 1997; 82: 3643-3646.
84. DiMeglio LA, Gagliardi PC, Browning JE, Quigley CA, Respaske DR. A missense mutation encoding Cys(67)→ Gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus. Mol Genet Metab 2001; 72: 39-44.
85. Santiprahob J, Browning JE, Repaske DR. A missense mutation encoding Cys73Phe in neurophysin II is associated with autosomal dominant neurohypophyseal diabetes insipidus. Mol Genet Metab 2002; 77: 112-118.
86. Baylis PH, Cheetham T. Diabetes insipidus. Arch Dis Child 1998; 79: 84-89.
87. Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, Bichet DG, Marumo F. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med 1995; 332: 1540-1545.
88. Kim RJ, Malattia C, Allen M, Moshang T, Maghnie M. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev 2004; 2 (Suppl 1): 115-123.
89. Boulgourdjian EM, Martinez AS, Ropelato MG, Heinrich JJ, Bergada C. Oral desmopressin treatment of central diabetes insipidus in children. Acta Paediatr 1997; 86: 1261-1262.
90. Fjellestad-Paulson A, Laborde K, Czernichow P. Water balance hormones during long-term follow-up of oral DDAVP treatment in diabetes insipidus. Acta Paediatr 1993; 82: 752-757.
91. Kauli R, Galatzer A, Laron Z. Treatment of diabetes insipidus in children and adolescents. In: Czernichow P, Robinson AG, eds. Diabetes Insipidus in Man. Front Horm Res 1985; 13: 304-313.
92. Maghnie M, Genovese E, Lundin S, Bonetti F, Aricò M. Iatrogenic extrapontine myelinolysis in central diabetes insipidus: Are cyclosporine and 1-desamino-8-D-arginine vasopressin harmful in association? J Clin Endocrinol Metab 1997; 82: 1749-1751.
93. Ball SG, Vaidja B, Baylis PH. Hypothalamic adipsic syndrome: diagnosis and management. Clin Endocrinol 1997; 47: 405-409.